Src Inhibition Can Synergize with Gemcitabine and Reverse Resistance in Triple Negative Breast Cancer Cells via the AKT/c-Jun Pathway

por Wu, Zhen-Hua, Lin, Chen, Liu, Ming-Ming, Zhang, Jian, Tao, Zhong-Hua, Hu, Xi-Chun
Publicado 2016

Apatinib plus vinorelbine versus vinorelbine for metastatic triple-negative breast cancer who failed first/second-line treatment: the NAN trial

por Li, Dou-Dou, Tao, Zhong-hua, Wang, Bi-Yun, Wang, Lei-Ping, Cao, Jun, Hu, Xi-Chun, Zhang, Jian
Publicado 2022

Isomalto oligosaccharide sulfate inhibits tumor growth and metastasis of hepatocellular carcinoma in nude mice

por Xiao, Chun-Li, Tao, Zhong-Hua, Guo, Lin, Li, Wei-Wei, Wan, Jin-Liang, Sun, Hui-Chuan, Wang, Lu, Tang, Zhao-You, Fan, Jia, Wu, Wei-Zhong
Publicado 2011

miR-612 suppresses the invasive-metastatic cascade in hepatocellular carcinoma

por Tao, Zhong-Hua, Wan, Jin-Liang, Zeng, Ling-Yao, Xie, Lu, Sun, Hui-Chuan, Qin, Lun-Xiu, Wang, Lu, Zhou, Jian, Ren, Zheng-Gang, Li, Yi-Xue, Fan, Jia, Wu, Wei-Zhong
Publicado 2013

Low level of ARID1A contributes to adaptive immune resistance and sensitizes triple‐negative breast cancer to immune checkpoint inhibitors

por Chen, Xin‐Yu, Li, Bin, Wang, Ye, Jin, Juan, Yang, Yu, Huang, Lei‐Huan, Yang, Meng‐Di, Zhang, Jian, Wang, Bi‐Yun, Shao, Zhi‐Ming, Ni, Ting, Huang, Sheng‐Lin, Hu, Xi‐Chun, Tao, Zhong‐Hua
Publicado 2023